United Therapeutics (UTHR) Insider Trading & Ownership $306.26 -3.77 (-1.21%) As of 09:55 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends United Therapeutics (NASDAQ:UTHR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$169.43 M Get UTHR Insider Trade Alerts Want to know when executives and insiders are buying or selling United Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address UTHR Insider Buying and Selling by Quarter United Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/24/2025Michael BenkowitzCOOSell10,000$360.76$3,607,600.00 2/18/2025Michael BenkowitzCOOSell10,000$371.05$3,710,500.00 2/10/2025Michael BenkowitzCOOSell10,000$348.06$3,480,600.00 2/3/2025Michael BenkowitzCOOSell10,000$353.64$3,536,400.00 1/27/2025Michael BenkowitzCOOSell10,000$370.71$3,707,100.00 1/21/2025Michael BenkowitzCOOSell10,000$364.91$3,649,100.00 1/13/2025Michael BenkowitzCOOSell10,000$364.62$3,646,200.00 12/30/2024Michael BenkowitzCOOSell10,000$356.68$3,566,800.00 12/30/2024Nilda MesaDirectorSell255$355.77$90,721.35 12/23/2024Michael BenkowitzCOOSell10,000$361.95$3,619,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/18/2024Louis W SullivanDirectorSell26,209$373.22$9,781,722.98 12/5/2024Paul A MahonEVPSell7,700$374.37$2,882,649.00 11/25/2024Michael BenkowitzCOOSell10,000$372.75$3,727,500.00 11/21/2024Paul A MahonEVPSell7,700$367.36$2,828,672.00 11/11/2024Judy D OlianDirectorSell1,750$412.48$721,840.00 11/11/2024Michael BenkowitzCOOSell15,000$407.32$6,109,800.00 11/8/2024Nilda MesaDirectorSell224$412.28$92,350.72 11/7/2024Michael BenkowitzCOOSell15,000$401.44$6,021,600.00 11/1/2024Christopher CauseyDirectorSell510$376.63$192,081.30 11/1/2024Michael BenkowitzCOOSell14,700$374.46$5,504,562.00 10/28/2024James EdgemondCFOSell7,800$350.00$2,730,000.00 10/21/2024James EdgemondCFOSell7,782$366.99$2,855,916.18 10/14/2024James EdgemondCFOSell7,792$355.88$2,773,016.96 10/7/2024James EdgemondCFOSell7,794$355.54$2,771,078.76 9/30/2024James EdgemondCFOSell7,792$358.62$2,794,367.04 9/23/2024James EdgemondCFOSell7,796$354.04$2,760,095.84 9/9/2024James EdgemondCFOSell7,802$345.41$2,694,888.82 9/3/2024James EdgemondCFOSell7,785$362.37$2,821,050.45 8/26/2024Martine A RothblattCEOSell269$348.41$93,722.29 8/19/2024Martine A RothblattCEOSell3,600$344.18$1,239,048.00 8/8/2024Martine A RothblattCEOSell3,600$328.39$1,182,204.00 8/7/2024Michael BenkowitzCOOSell25,000$323.38$8,084,500.00 8/6/2024Martine A RothblattCEOSell3,600$325.45$1,171,620.00 8/2/2024Martine A RothblattCEOSell3,600$324.73$1,169,028.00 8/2/2024Raymond DwekDirectorSell5,000$325.35$1,626,750.00 7/30/2024Martine A RothblattCEOSell3,600$337.40$1,214,640.00 7/26/2024Martine A RothblattCEOSell3,600$338.61$1,218,996.00 7/24/2024Martine A RothblattCEOSell3,600$334.00$1,202,400.00 7/22/2024Martine A RothblattCEOSell3,600$331.32$1,192,752.00 7/18/2024Martine A RothblattCEOSell3,600$331.79$1,194,444.00 “Amazon Coin” set to outperform Bitcoin (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…#1 FREE Crypto for 20257/16/2024Martine A RothblattCEOSell3,600$328.03$1,180,908.00 7/12/2024Martine A RothblattCEOSell3,600$324.97$1,169,892.00 7/10/2024Martine A RothblattCEOSell3,600$326.35$1,174,860.00 7/8/2024Martine A RothblattCEOSell3,600$317.05$1,141,380.00 7/5/2024Martine A RothblattCEOSell3,600$313.25$1,127,700.00 7/3/2024Martine A RothblattCEOSell3,600$312.48$1,124,928.00 7/1/2024Martine A RothblattCEOSell3,600$320.45$1,153,620.00 6/27/2024Martine A RothblattCEOSell3,600$316.62$1,139,832.00 6/25/2024Nilda MesaDirectorSell266$318.58$84,742.28 6/24/2024Martine A RothblattCEOSell3,600$315.97$1,137,492.00 6/21/2024Martine A RothblattCEOSell3,600$313.91$1,130,076.00 6/14/2024Martine A RothblattCEOSell3,600$287.22$1,033,992.00 6/13/2024Christopher CauseyDirectorSell2,000$281.53$563,060.00 6/12/2024Martine A RothblattCEOSell3,600$281.19$1,012,284.00 6/10/2024Martine A RothblattCEOSell3,600$273.95$986,220.00 6/7/2024Martine A RothblattCEOSell3,600$277.13$997,668.00 5/31/2024Martine A RothblattCEOSell3,600$272.48$980,928.00 5/28/2024Martine A RothblattDirectorSell3,600$269.06$968,616.00 5/23/2024Martine A RothblattDirectorSell3,600$275.78$992,808.00 5/21/2024Martine A RothblattDirectorSell1,468$275.85$404,947.80 5/16/2024Martine A RothblattDirectorSell3,600$272.37$980,532.00 5/14/2024Christopher PatuskyDirectorSell1,310$264.35$346,298.50 5/13/2024Martine A RothblattCEOSell3,600$265.48$955,728.00 5/9/2024Martine A RothblattCEOSell3,600$264.22$951,192.00 5/6/2024Martine A RothblattCEOSell3,600$259.70$934,920.00 5/3/2024Christopher CauseyDirectorSell2,240$259.91$582,198.40 5/2/2024Martine A RothblattCEOSell3,600$258.09$929,124.00 4/30/2024Martine A RothblattCEOSell3,600$235.35$847,260.00 4/26/2024Martine A RothblattCEOSell3,600$235.20$846,720.00 4/24/2024Martine A RothblattCEOSell3,600$238.81$859,716.00 4/22/2024Martine A RothblattCEOSell3,600$236.47$851,292.00 4/18/2024Martine A RothblattCEOSell3,600$237.91$856,476.00 4/16/2024Martine A RothblattCEOSell3,600$232.05$835,380.00 4/12/2024Martine A RothblattCEOSell3,600$235.42$847,512.00 4/10/2024Martine A RothblattCEOSell13,800$237.27$3,274,326.00 4/8/2024Martine A RothblattCEOSell5,060$237.52$1,201,851.20 4/4/2024Martine A RothblattCEOSell15,000$233.27$3,499,050.00 4/4/2024Paul A MahonEVPSell6,000$232.37$1,394,220.00 3/28/2024Martine A RothblattCEOSell14,125$236.18$3,336,042.50 3/27/2024Nilda MesaDirectorSell325$237.80$77,285.00 3/26/2024Martine A RothblattCEOSell15,000$248.33$3,724,950.00 3/22/2024Martine A RothblattCEOSell15,000$237.05$3,555,750.00 3/21/2024Paul A MahonEVPSell6,000$236.45$1,418,700.00 3/19/2024Martine A RothblattCEOSell15,000$236.59$3,548,850.00 (Data available from 1/1/2013 forward) UTHR Insider Trading Activity - Frequently Asked Questions Who is on United Therapeutics's Insider Roster? The list of insiders at United Therapeutics includes Christopher Causey, Christopher Patusky, James Edgemond, Judy D Olian, Louis W Sullivan, Martine A Rothblatt, Michael Benkowitz, Nilda Mesa, Paul A Mahon, and Raymond Dwek. Learn more on insiders at UTHR. What percentage of United Therapeutics stock is owned by insiders? 11.90% of United Therapeutics stock is owned by insiders. Learn more on UTHR's insider holdings. Which United Therapeutics insiders have been buying company stock? The following insider purchased UTHR shares in the last 24 months: Christopher Patusky ($684.36). How much insider buying is happening at United Therapeutics? Insiders have purchased a total of 6 UTHR shares in the last 24 months for a total of $684.36 bought. Which United Therapeutics insiders have been selling company stock? The following insiders have sold UTHR shares in the last 24 months: Christopher Causey ($2,086,379.70), Christopher Patusky ($723,157.05), James Edgemond ($22,200,414.05), Judy D Olian ($721,840.00), Louis W Sullivan ($9,781,722.98), Martine A Rothblatt ($96,847,437.79), Michael Benkowitz ($61,971,762.00), Nilda Mesa ($658,766.67), Paul A Mahon ($35,865,176.00), and Raymond Dwek ($1,626,750.00). How much insider selling is happening at United Therapeutics? Insiders have sold a total of 811,601 United Therapeutics shares in the last 24 months for a total of $232,483,406.24 sold. United Therapeutics Key ExecutivesDr. Martine A. Rothblatt J.D. (Age 69)M.B.A., Ph.D., Founder, Chairman & CEO Compensation: $5.66MMr. Michael I. Benkowitz (Age 52)President & COO Compensation: $3.26M13 recent tradesMr. James C. Edgemond (Age 56)CFO & Treasurer Compensation: $2.15M7 recent tradesMr. Paul A. Mahon J.D. (Age 60)Executive VP, General Counsel & Corporate Secretary Compensation: $2.44M2 recent tradesMr. Dewey Steadman C.F.A.Head of Investor RelationsMs. Holly HobsonAssociate Vice President of Human ResourcesKevin T. GraySenior Vice President of Strategic Operations & LogisticsMr. Patrick Poisson (Age 56)Executive VP of Technical Operations Dr. Leigh PetersonExecutive Vice President of Product Development & XenotransplantationMr. Gil GoldenSenior VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies ALNY Insider Selling BIIB Insider Selling INCY Insider Selling BMRN Insider Selling NBIX Insider Selling EXEL Insider Selling EXAS Insider Selling RGEN Insider Selling HALO Insider Selling MDGL Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:UTHR) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredWhy 2026 will be a disaster for many AmericansWall Street Legend: Why stocks are very likely to crash in Trump's 2nd Year Legendary investor Marc Chaikin...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UTHR Stock Alerts